Results for tag: "Gigantism Drug"

Gigantism Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. It is composed of drugs used to treat Gigantism, a condition caused by an excess of growth hormone in the body. These drugs are used to reduce the amount of growth hormone in the body, thus reducing the symptoms of Gigantism. Common drugs used to treat Gigantism include somatostatin analogs, dopamine agonists, and growth hormone receptor antagonists. These drugs are typically administered through injections or oral medications. The Gigantism Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Novartis, Pfizer, Sanofi, Merck, and Eli Lilly. These companies are constantly innovating and developing new treatments to meet the needs of patients. Show Less Read more